首页 > 最新文献

Einstein-Sao Paulo最新文献

英文 中文
Cost-benefit analysis of implementing Vendor Neutral Archive (VNA) technology in the Brazilian Public Health System. 在巴西公共卫生系统实施供应商中立档案(VNA)技术的成本效益分析。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025GS1219
Giulia Osório Santana, Luis Gustavo Nascimento de Paula, Leandro Seiti Anazawa, Pedro Vieira Santana Netto, Aline de Souza Moura, Daniel Tornieri, Joselisa Péres Queiroz de Paiva, Rafael Maffei Loureiro, William Yang Chen Fan, Ligia Bueno Sandes, Lucas Reis Correia

Objective: To conduct an ex-ante cost-benefit analysis of implementing Vendor Neutral Archive technology in the Brazilian Public Health System.

Methods: The cost-benefit analysis involves monetizing the potential costs and benefits of implementing Vendor Neutral Archive in the Brazilian Public Health System, focusing on comparing these values using the return on investment measure.

Results: The aggregate analysis at the Brazilian Public Health System level reveals that the estimated return on investment for the first year after Vendor Neutral Archive implementation is 5.63%, rising to 10.12% after three years. The results indicate a positive correlation between the number of imaging exams conducted and the financial gains for the health institution under analysis. A minimum number of approximately 11,500 exams is required to implement Vendor Neutral Archive technology to generate positive returns in the first year after implementation.

Conclusion: Despite the importance of interpreting results cautiously owing to assumptions and methodological limitations, the findings highlight the strategic significance of Vendor Neutral Archive in enhancing the efficiency and sustainability of the Brazilian Public Health System. Adopting cloud-based medical image storage requires a significant upfront investment but promises substantial benefits. Within the Brazilian Public Health System, the return on this investment can be realized in less than one year, correlated with the volume of imaging exams performed. This underscores the importance of scalability in the healthcare system, where wider adoption of Vendor Neutral Archive results in higher returns.

Background: ■ Vendor Neutral Archive implementation has an return on investment of 5.63% in the first year and 10.12% after three years.

Background: ■ At least 11,500 exams are needed annually for a positive return on investment in the first year after implementation.

Background: ■ Vendor Neutral Archive enhances interoperability and efficiency by standardizing and centralizing image storage.

Background: ■ Scalability is key: higher adoption of Vendor Neutral Archive leads to greater financial and operational benefits.

Background: Vendor Neutral Archive is a centralized, cloud-based solution that enables interoperable storage and management of medical images. Vendor Neutral Archive enhances data accessibility and long-term cost efficiency, supporting a more scalable and sustainable healthcare infrastructure. This study conducts a cost-benefit analysis of implementing Vendor Neutral Archive technology in the Brazilian Public Health System.

目的:对巴西公共卫生系统实施供应商中立档案技术进行事前成本效益分析。方法:成本效益分析包括货币化在巴西公共卫生系统中实施供应商中立档案的潜在成本和收益,重点是使用投资回报措施比较这些价值。结果:巴西公共卫生系统层面的综合分析显示,供应商中立档案实施后第一年的投资回报率估计为5.63%,三年后上升到10.12%。结果表明,所进行的影像学检查次数与所分析的卫生机构的财务收益之间存在正相关关系。为了在实施供应商中立存档技术后的第一年产生积极的回报,至少需要进行大约11,500次考试。结论:尽管由于假设和方法上的限制,谨慎解释结果很重要,但研究结果强调了供应商中立档案在提高巴西公共卫生系统的效率和可持续性方面的战略意义。采用基于云的医疗图像存储需要大量的前期投资,但保证了可观的收益。在巴西公共卫生系统内,这项投资的回报可以在不到一年的时间内实现,这与所进行的影像学检查的数量相关。这强调了可伸缩性在医疗保健系统中的重要性,更广泛地采用供应商中立存档会带来更高的回报。背景:■供应商中立档案实施第一年的投资回报率为5.63%,三年后为10.12%。背景:■为了在实施后的第一年获得积极的投资回报,每年至少需要11500次考试。背景:■供应商中立存档通过标准化和集中化映像存储来增强互操作性和效率。背景:■可扩展性是关键:供应商中立档案的高采用率会带来更大的财务和运营效益。背景:Vendor Neutral Archive是一种集中式、基于云的解决方案,可实现医学图像的互操作存储和管理。供应商中立存档增强了数据可访问性和长期成本效率,支持更具可扩展性和可持续性的医疗保健基础设施。本研究对在巴西公共卫生系统中实施供应商中立档案技术进行了成本效益分析。
{"title":"Cost-benefit analysis of implementing Vendor Neutral Archive (VNA) technology in the Brazilian Public Health System.","authors":"Giulia Osório Santana, Luis Gustavo Nascimento de Paula, Leandro Seiti Anazawa, Pedro Vieira Santana Netto, Aline de Souza Moura, Daniel Tornieri, Joselisa Péres Queiroz de Paiva, Rafael Maffei Loureiro, William Yang Chen Fan, Ligia Bueno Sandes, Lucas Reis Correia","doi":"10.31744/einstein_journal/2025GS1219","DOIUrl":"10.31744/einstein_journal/2025GS1219","url":null,"abstract":"<p><strong>Objective: </strong>To conduct an ex-ante cost-benefit analysis of implementing Vendor Neutral Archive technology in the Brazilian Public Health System.</p><p><strong>Methods: </strong>The cost-benefit analysis involves monetizing the potential costs and benefits of implementing Vendor Neutral Archive in the Brazilian Public Health System, focusing on comparing these values using the return on investment measure.</p><p><strong>Results: </strong>The aggregate analysis at the Brazilian Public Health System level reveals that the estimated return on investment for the first year after Vendor Neutral Archive implementation is 5.63%, rising to 10.12% after three years. The results indicate a positive correlation between the number of imaging exams conducted and the financial gains for the health institution under analysis. A minimum number of approximately 11,500 exams is required to implement Vendor Neutral Archive technology to generate positive returns in the first year after implementation.</p><p><strong>Conclusion: </strong>Despite the importance of interpreting results cautiously owing to assumptions and methodological limitations, the findings highlight the strategic significance of Vendor Neutral Archive in enhancing the efficiency and sustainability of the Brazilian Public Health System. Adopting cloud-based medical image storage requires a significant upfront investment but promises substantial benefits. Within the Brazilian Public Health System, the return on this investment can be realized in less than one year, correlated with the volume of imaging exams performed. This underscores the importance of scalability in the healthcare system, where wider adoption of Vendor Neutral Archive results in higher returns.</p><p><strong>Background: </strong>■ Vendor Neutral Archive implementation has an return on investment of 5.63% in the first year and 10.12% after three years.</p><p><strong>Background: </strong>■ At least 11,500 exams are needed annually for a positive return on investment in the first year after implementation.</p><p><strong>Background: </strong>■ Vendor Neutral Archive enhances interoperability and efficiency by standardizing and centralizing image storage.</p><p><strong>Background: </strong>■ Scalability is key: higher adoption of Vendor Neutral Archive leads to greater financial and operational benefits.</p><p><strong>Background: </strong>Vendor Neutral Archive is a centralized, cloud-based solution that enables interoperable storage and management of medical images. Vendor Neutral Archive enhances data accessibility and long-term cost efficiency, supporting a more scalable and sustainable healthcare infrastructure. This study conducts a cost-benefit analysis of implementing Vendor Neutral Archive technology in the Brazilian Public Health System.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eGS1219"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Myopericytoma of the thoracic spine in a pregnant woman: a case report on the management of a rare neoplasm. 孕妇胸椎肌外皮细胞瘤:一例罕见肿瘤的治疗报告。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025RC1150
Adriano Jander Ferreira, Túlio Luiz Marra Négri, Julia Hailer Vieira, Anderson Alves Dias, Mellanie Starck Possa, Giovanni Bessa Pereira Lima

Myopericytomas are perivascular myoid neoplasms that rarely exhibit malignant characteristics. They usually arise in the dermis or subcutaneous tissue and exceptionally involve deep soft tissues, with spinal localization being rare. We report the case of a previously healthy 32-year-old pregnant woman who presented with pain in the interscapular region and progressive loss of lower limb strength. Magnetic resonance imaging revealed a solid neoplastic mass at the T3 level, with spinal canal invasion and spinal cord signal abnormalities. The pregnancy was terminated, followed by lesion embolization, decompressive laminectomy, and local radiotherapy. The patient completely recovered from her neurological symptoms. Thoracic spine myopericytomas are rare and have been poorly reported in the literature. No studies have described the aforementioned neoplasm in a pregnant patient. We report this case because of its peculiarity, evolution, and outcome.

肌外皮细胞瘤是血管周围的肌样肿瘤,很少表现出恶性特征。它们通常发生在真皮或皮下组织,特别涉及深层软组织,脊柱定位罕见。我们报告的情况下,以前健康的32岁孕妇谁提出在肩胛间区疼痛和下肢力量进行性丧失。磁共振成像显示T3水平实性肿瘤肿块,伴椎管侵犯及脊髓信号异常。终止妊娠,随后病变栓塞,减压椎板切除术,局部放疗。病人的神经症状完全恢复了。胸椎肌外皮细胞瘤是罕见的,文献报道很少。没有研究描述上述肿瘤在怀孕患者。我们报告这个病例是因为它的特殊性,演变和结果。
{"title":"Myopericytoma of the thoracic spine in a pregnant woman: a case report on the management of a rare neoplasm.","authors":"Adriano Jander Ferreira, Túlio Luiz Marra Négri, Julia Hailer Vieira, Anderson Alves Dias, Mellanie Starck Possa, Giovanni Bessa Pereira Lima","doi":"10.31744/einstein_journal/2025RC1150","DOIUrl":"10.31744/einstein_journal/2025RC1150","url":null,"abstract":"<p><p>Myopericytomas are perivascular myoid neoplasms that rarely exhibit malignant characteristics. They usually arise in the dermis or subcutaneous tissue and exceptionally involve deep soft tissues, with spinal localization being rare. We report the case of a previously healthy 32-year-old pregnant woman who presented with pain in the interscapular region and progressive loss of lower limb strength. Magnetic resonance imaging revealed a solid neoplastic mass at the T3 level, with spinal canal invasion and spinal cord signal abnormalities. The pregnancy was terminated, followed by lesion embolization, decompressive laminectomy, and local radiotherapy. The patient completely recovered from her neurological symptoms. Thoracic spine myopericytomas are rare and have been poorly reported in the literature. No studies have described the aforementioned neoplasm in a pregnant patient. We report this case because of its peculiarity, evolution, and outcome.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eRC1150"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transrectal prostate biopsy complications: a prospective single center study in a mid-income country. 经直肠前列腺活检并发症:一项中等收入国家的前瞻性单中心研究。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025AO1437
Allan Jefferson Schollemberg, Flavio Lobo Heldwein, Suelen Dos Santos, Vítor Maurício Merlin Maschietto, Erick Schnorrenberger, Kleber Reinert, Gabriela Garcia Korczaguin, Marcelo Langer Wroclawski

Objective: To identify complications following transrectal posterior biopsies in a public Brazilian reference center, and to identify the risk factors associated with complications.

Methods: This is a prospective cohort study that employed a form designed by the Global Prevalence Infections in Urology study. Data from 1,043 consecutive patients who underwent transrectal prostate biopsy at a single Brazilian center were analyzed, including patient characteristics, procedural characteristics, and self-assessed complications at 28 days. Complications were categorized according to the Clavien-Dindo (CD) classification.

Results: Most bleeding complications were mild (CD Grade 1), although 1.5% reported Grades 2-3. Hypertension, younger age, and anticoagulant use were associated with bleeding (all p<0.001). A total of 4.7% reported infections (CD Grade 2: 0.5%, CD Grade 3: 3.6%, and CD Grade 4 [sepsis]: 0.6%), with risk factors being indwelling catheter use, recent urinary tract infection (p<0.001 for both), and quinolone use (OR= 3.01, 95%CI= 1.15-7.80, p=0.03). Urinary retention was observed in 4.1% (Grade 2), with severe symptoms (p=0.009), prostates >89mL (p=0.001), and prostatic protrusion ≥10mm (p=0.001) being associated with it.

Conclusion: Clinically significant (CD Grades 3-5) adverse effects of transrectal prostate biopsy are rare. Careful pre-procedure evaluation of antimicrobial use, particularly quinolones, along with the assessment of identified risk factors is essential for counseling patients and reducing potential risks.

Background: ■ This prospective cohort study assessed prostate biopsy complications in 1,043 men.

Background: ■ The major outcomes included bleeding (Clavien-Dindo Grades 2-3 = 1.5%), infections (4.7%), and urinary retention (4.1%).

Background: ■ The key risk factors for infection were recent quinolone use, indwelling catheters, and high PSA levels.

Background: ■ Acute urinary retention was linked to untreated lower urinary tract symptoms, prostate volume, intravesical prostatic protrusion, and bladder wall thickness.

Background: This prospective study conducted in a mid-income country evaluated the risk factors associated with complications after transrectal prostate biopsy and highlighted significant correlations with hemorrhagic events, infections, and acute urinary retention.

目的:在巴西公共参考中心确定经直肠后活检后的并发症,并确定与并发症相关的危险因素。方法:这是一项前瞻性队列研究,采用全球泌尿科流行感染研究设计的形式。在巴西的一个中心,对1043例连续接受经直肠前列腺活检的患者的数据进行了分析,包括患者特征、手术特征和28天的自我评估并发症。并发症按Clavien-Dindo (CD)分类。结果:大多数出血并发症是轻微的(CD 1级),尽管1.5%报告了2-3级。高血压、年轻和使用抗凝剂与出血相关(均为p89mL (p=0.001)),前列腺突出≥10mm (p=0.001)与出血相关。结论:经直肠前列腺活检临床显著的不良反应(CD分级3-5)是罕见的。对抗菌素使用,特别是喹诺酮类药物使用进行仔细的术前评估,同时评估已确定的风险因素,对于向患者提供咨询和降低潜在风险至关重要。背景:这项前瞻性队列研究评估了1043名男性的前列腺活检并发症。主要结局包括出血(Clavien-Dindo分级2-3 = 1.5%)、感染(4.7%)和尿潴留(4.1%)。背景:感染的主要危险因素是近期使用喹诺酮类药物、留置导管和PSA水平升高。背景:急性尿潴留与未经治疗的下尿路症状、前列腺体积、膀胱内前列腺突出和膀胱壁厚度有关。背景:这项在中等收入国家进行的前瞻性研究评估了经直肠前列腺活检后并发症的相关危险因素,并强调了出血事件、感染和急性尿潴留的显著相关性。
{"title":"Transrectal prostate biopsy complications: a prospective single center study in a mid-income country.","authors":"Allan Jefferson Schollemberg, Flavio Lobo Heldwein, Suelen Dos Santos, Vítor Maurício Merlin Maschietto, Erick Schnorrenberger, Kleber Reinert, Gabriela Garcia Korczaguin, Marcelo Langer Wroclawski","doi":"10.31744/einstein_journal/2025AO1437","DOIUrl":"10.31744/einstein_journal/2025AO1437","url":null,"abstract":"<p><strong>Objective: </strong>To identify complications following transrectal posterior biopsies in a public Brazilian reference center, and to identify the risk factors associated with complications.</p><p><strong>Methods: </strong>This is a prospective cohort study that employed a form designed by the Global Prevalence Infections in Urology study. Data from 1,043 consecutive patients who underwent transrectal prostate biopsy at a single Brazilian center were analyzed, including patient characteristics, procedural characteristics, and self-assessed complications at 28 days. Complications were categorized according to the Clavien-Dindo (CD) classification.</p><p><strong>Results: </strong>Most bleeding complications were mild (CD Grade 1), although 1.5% reported Grades 2-3. Hypertension, younger age, and anticoagulant use were associated with bleeding (all p<0.001). A total of 4.7% reported infections (CD Grade 2: 0.5%, CD Grade 3: 3.6%, and CD Grade 4 [sepsis]: 0.6%), with risk factors being indwelling catheter use, recent urinary tract infection (p<0.001 for both), and quinolone use (OR= 3.01, 95%CI= 1.15-7.80, p=0.03). Urinary retention was observed in 4.1% (Grade 2), with severe symptoms (p=0.009), prostates >89mL (p=0.001), and prostatic protrusion ≥10mm (p=0.001) being associated with it.</p><p><strong>Conclusion: </strong>Clinically significant (CD Grades 3-5) adverse effects of transrectal prostate biopsy are rare. Careful pre-procedure evaluation of antimicrobial use, particularly quinolones, along with the assessment of identified risk factors is essential for counseling patients and reducing potential risks.</p><p><strong>Background: </strong>■ This prospective cohort study assessed prostate biopsy complications in 1,043 men.</p><p><strong>Background: </strong>■ The major outcomes included bleeding (Clavien-Dindo Grades 2-3 = 1.5%), infections (4.7%), and urinary retention (4.1%).</p><p><strong>Background: </strong>■ The key risk factors for infection were recent quinolone use, indwelling catheters, and high PSA levels.</p><p><strong>Background: </strong>■ Acute urinary retention was linked to untreated lower urinary tract symptoms, prostate volume, intravesical prostatic protrusion, and bladder wall thickness.</p><p><strong>Background: </strong>This prospective study conducted in a mid-income country evaluated the risk factors associated with complications after transrectal prostate biopsy and highlighted significant correlations with hemorrhagic events, infections, and acute urinary retention.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eAO1437"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144974087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristic competencies for effective teachers in healthcare education. 健康教育中有效教师的特征能力。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025RW1360
Marina Iahn-Aun, Marcelo Vivolo Aun, Welbert Oliveira Pereira

Teachers have the significant potential to facilitate alterations in the teaching-learning process that can positively affect student outcomes. In the healthcare field, exposure to effective teachers is associated with enhanced clinical performance and student knowledge. The literature explores several characteristics that increase the possibility of obtaining better outcomes when developed by teachers. These features are described from the perspectives of students, managers, and teachers. However, when considering teacher development programs, it is necessary to translate these characteristics, skills, and personality traits into competencies for training and enhancement. Therefore, in this review, we propose eight primary competencies that encompass the majority of these previously described characteristics: knowledge, communication skills, empathy, ability to facilitate engagement, preparation, organization, ability to assess learning progress, self-reflection, and continuous enhancement. All of these are trainable. However, teacher training is a complex and continuous process. Understanding these competencies is crucial for designing effective teacher development programs that offer measurable outcomes, reinforce teaching adherence, optimize enhancement timelines, and reduce institutional costs. This review discusses each of the eight competencies, their interrelationships, and their effects on healthcare education, offering a foundation for teachers and managers to facilitate educational excellence.

教师有很大的潜力来促进教学过程的改变,从而对学生的成绩产生积极的影响。在医疗保健领域,接触有效的教师与提高临床表现和学生知识有关。该文献探讨了几个特点,增加了教师开发时获得更好结果的可能性。这些特征分别从学生、管理者和教师的角度进行了描述。然而,在考虑教师发展计划时,有必要将这些特征、技能和人格特征转化为培训和提高的能力。因此,在这篇综述中,我们提出了八个主要能力,涵盖了前面描述的大部分特征:知识、沟通技巧、同理心、促进参与的能力、准备、组织、评估学习进度的能力、自我反思和持续提升。所有这些都是可训练的。然而,教师培训是一个复杂而持续的过程。了解这些能力对于设计有效的教师发展计划至关重要,这些计划可以提供可衡量的结果,加强教学依从性,优化改进时间表,并降低机构成本。这篇综述讨论了八种能力、它们之间的相互关系以及它们对保健教育的影响,为教师和管理者促进教育卓越提供了基础。
{"title":"Characteristic competencies for effective teachers in healthcare education.","authors":"Marina Iahn-Aun, Marcelo Vivolo Aun, Welbert Oliveira Pereira","doi":"10.31744/einstein_journal/2025RW1360","DOIUrl":"10.31744/einstein_journal/2025RW1360","url":null,"abstract":"<p><p>Teachers have the significant potential to facilitate alterations in the teaching-learning process that can positively affect student outcomes. In the healthcare field, exposure to effective teachers is associated with enhanced clinical performance and student knowledge. The literature explores several characteristics that increase the possibility of obtaining better outcomes when developed by teachers. These features are described from the perspectives of students, managers, and teachers. However, when considering teacher development programs, it is necessary to translate these characteristics, skills, and personality traits into competencies for training and enhancement. Therefore, in this review, we propose eight primary competencies that encompass the majority of these previously described characteristics: knowledge, communication skills, empathy, ability to facilitate engagement, preparation, organization, ability to assess learning progress, self-reflection, and continuous enhancement. All of these are trainable. However, teacher training is a complex and continuous process. Understanding these competencies is crucial for designing effective teacher development programs that offer measurable outcomes, reinforce teaching adherence, optimize enhancement timelines, and reduce institutional costs. This review discusses each of the eight competencies, their interrelationships, and their effects on healthcare education, offering a foundation for teachers and managers to facilitate educational excellence.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eRW1360"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term effects of remote ischemic conditioning on vascular function in patients with cardiovascular diseases: a systematic review with meta-analysis. 远程缺血调节对心血管疾病患者血管功能的短期影响:一项meta分析的系统综述
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025RW1937
Samuel Amorim, Gilberto Laurentino, Victor Sabino de Queiros, Yujia Liu, Per Aagaard, Charlotte Suetta, Naufal Zagidullin, Kenneth J Gollob

Objective: The purpose of this systematic review with meta-analysis was to compare the short-term (≤1 month) effects of remote ischemic conditioning versus sham remote ischemic conditioning on vascular function in patients with cardiovascular diseases.

Methods: A systematic review was conducted to identify relevant studies through six healthcare science databases up to March 2025. Arterial stiffness and endothelial function were defined as the primary outcome. Meta-analyses were performed using a random-effect model. Also, GRADE Pro software was used to evaluate the quality of evidence.

Results: A total of 7 randomized clinical trials with 603 patients with cardiovascular diseases were included in the systematic review. Also, we included 5 studies in the meta-analysis. Compared with sham remote ischemic conditioning or control, short-term remote ischemic conditioning resulted in enhanced endothelial function (MD=4.22% [95%CI=1.75; 6.69]; p=0.0008; I2=0%) without any changes in arterial stiffness, (MD=-0.05 m/s [95%CI =-0.77, 0.67]; p=0.89; I2=89%).

Conclusion: This systematic review and meta-analysis found that short-term remote ischemic conditioning was associated with improvements in endothelial function compared with sham remote ischemic conditioning or control in cardiovascular patients, without any impact on arterial stiffness.

Prospero database registration: ID CRD42021234702.

目的:本系统综述结合meta分析的目的是比较远程缺血适应与假远程缺血适应对心血管疾病患者血管功能的短期(≤1个月)影响。方法:对截至2025年3月的6个卫生科学数据库进行系统回顾,筛选相关研究。动脉僵硬度和内皮功能被定义为主要终点。采用随机效应模型进行meta分析。同时,GRADE Pro软件用于评价证据质量。结果:系统评价共纳入7项随机临床试验603例心血管疾病患者。此外,我们在meta分析中纳入了5项研究。与假性远端缺血调节或对照组相比,短期远端缺血调节导致内皮功能增强(MD=4.22% [95%CI=1.75; 6.69]; p=0.0008; I2=0%),动脉硬度未见改变(MD=-0.05 m/s [95%CI= -0.77, 0.67]; p=0.89; I2=89%)。结论:本系统综述和荟萃分析发现,与假性远端缺血调节或对照组相比,短期远端缺血调节与心血管患者内皮功能改善相关,对动脉硬度没有任何影响。普洛斯彼罗数据库注册:ID CRD42021234702。
{"title":"Short-term effects of remote ischemic conditioning on vascular function in patients with cardiovascular diseases: a systematic review with meta-analysis.","authors":"Samuel Amorim, Gilberto Laurentino, Victor Sabino de Queiros, Yujia Liu, Per Aagaard, Charlotte Suetta, Naufal Zagidullin, Kenneth J Gollob","doi":"10.31744/einstein_journal/2025RW1937","DOIUrl":"10.31744/einstein_journal/2025RW1937","url":null,"abstract":"<p><strong>Objective: </strong>The purpose of this systematic review with meta-analysis was to compare the short-term (≤1 month) effects of remote ischemic conditioning versus sham remote ischemic conditioning on vascular function in patients with cardiovascular diseases.</p><p><strong>Methods: </strong>A systematic review was conducted to identify relevant studies through six healthcare science databases up to March 2025. Arterial stiffness and endothelial function were defined as the primary outcome. Meta-analyses were performed using a random-effect model. Also, GRADE Pro software was used to evaluate the quality of evidence.</p><p><strong>Results: </strong>A total of 7 randomized clinical trials with 603 patients with cardiovascular diseases were included in the systematic review. Also, we included 5 studies in the meta-analysis. Compared with sham remote ischemic conditioning or control, short-term remote ischemic conditioning resulted in enhanced endothelial function (MD=4.22% [95%CI=1.75; 6.69]; p=0.0008; I2=0%) without any changes in arterial stiffness, (MD=-0.05 m/s [95%CI =-0.77, 0.67]; p=0.89; I2=89%).</p><p><strong>Conclusion: </strong>This systematic review and meta-analysis found that short-term remote ischemic conditioning was associated with improvements in endothelial function compared with sham remote ischemic conditioning or control in cardiovascular patients, without any impact on arterial stiffness.</p><p><strong>Prospero database registration: </strong>ID CRD42021234702.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eRW1937"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multifocal papillary thyroid microcarcinomas: is the total tumor diameter associated with the tumor behavior? A retrospective cohort study. 多灶性甲状腺乳头状微癌:肿瘤总直径与肿瘤行为有关吗?回顾性队列研究。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025AO1724
Larissa Ariane de Nardi, Ana Flávia Aguiar Ribeiro Coutinho, Carlos Segundo Paiva Soares, Simone Antunes Terra, Cristiano Claudino de Oliveira, Katia Hiromoto Koga, Sonia Marta Moriguchi, José Vicente Tagliarini, Gláucia Maria Ferreira da Silva Mazeto

Objective: To evaluate whether the total tumor diameter (sum of the largest diameters of all foci) predicts tumor aggressiveness at initial presentation and treatment response at 1-year follow-up in patients with multifocal papillary thyroid microcarcinoma.

Methods: A retrospective analysis was conducted on 475 patients with differentiated thyroid carcinoma. Fifty-two patients with multifocal papillary thyroid microcarcinoma were included. The primary variable was total tumor diameter, and outcomes included initial tumor aggressiveness, evaluated according to the American Joint Committee on Cancer (AJCC; stages I or II), risk of recurrence according to the American Thyroid Association (low or not low), and response to therapy at 1 year (excellent or not).

Results: AJCC stage II disease was significantly associated with age ≥55 years, lymph node dissection, angiolymphatic invasion, extrathyroidal extension, lymph node metastasis, number of metastatic lymph nodes, non-low risk of recurrence, first stimulated thyroglobulin, and response to therapy at 1-year. Non-low risk of recurrence were associated with Bethesda V/VI cytology, lymph node dissection, angiolymphatic and tumor capsule invasion, extrathyroidal extension, lymph node metastasis, number of metastatic lymph nodes, first stimulated thyroglobulin, and radioiodine dose. Non-excellent response at 1-year follow-up were associated with preoperative thyroid-stimulating hormone levels, lymph node metastasis, number of metastatic lymph nodes, and first stimulated thyroglobulin. Multivariate analysis revealed that only the number of metastatic lymph nodes independently predicted AJCC stage.

Conclusion: Total tumor diameter was not associated with initial tumor aggressiveness or treatment response at 1-year follow-up in patients with multifocal papillary thyroid microcarcinoma.

Background: ■ In multifocal papillary thyroid microcarcinomas.

Background: ■ The total tumor diameter was not associated with aggressiveness or initial evolution.

Background: ■ Other factors are associated with disease outcomes.

Background: ■ The number of metastatic lymph nodes is an independent predictor of American Joint Committee on Cancer stage.

Background: This study demonstrated that in multifocal papillary thyroid microcarcinomas, the sum of the largest diameters of all tumor foci was not associated with tumor aggressiveness or response to therapy at 1-year follow-up. Conversely, the total number of metastatic lymph nodes was an independent predictor of American Joint Committee on Cancer staging.

目的:评价肿瘤总直径(所有病灶最大直径之和)能否预测多灶性甲状腺乳头状微癌患者首发时的肿瘤侵袭性和1年随访时的治疗效果。方法:对475例分化型甲状腺癌患者进行回顾性分析。包括52例多灶性甲状腺乳头状微癌患者。主要变量是肿瘤总直径,结果包括初始肿瘤侵袭性,根据美国癌症联合委员会(AJCC, I期或II期)评估,根据美国甲状腺协会评估的复发风险(低或不低),以及1年的治疗反应(优秀或不优秀)。结果:AJCC II期疾病与年龄≥55岁、淋巴结清扫、血管淋巴浸润、甲状腺外展、淋巴结转移、转移淋巴结数量、非低复发风险、首次刺激甲状腺球蛋白和1年治疗反应显著相关。非低复发风险与Bethesda V/VI细胞学、淋巴结清扫、血管淋巴和肿瘤囊浸润、甲状腺外展、淋巴结转移、转移淋巴结数量、首次刺激甲状腺球蛋白和放射性碘剂量有关。1年随访时不良反应与术前促甲状腺激素水平、淋巴结转移、转移淋巴结数量和首次刺激甲状腺球蛋白有关。多因素分析显示,只有转移淋巴结的数量能独立预测AJCC的分期。结论:在多灶性甲状腺乳头状微癌患者的1年随访中,肿瘤总直径与初始肿瘤侵袭性或治疗反应无关。背景:■多灶性甲状腺乳头状微癌。背景:■肿瘤总直径与侵袭性或初始进化无关。背景:■其他因素与疾病结局相关。背景:■转移性淋巴结的数量是美国癌症分期联合委员会的独立预测指标。背景:本研究表明,在多灶性甲状腺乳头状微癌中,所有肿瘤病灶的最大直径之和与肿瘤侵袭性或1年随访时对治疗的反应无关。相反,转移性淋巴结的总数是美国癌症分期联合委员会的独立预测因子。
{"title":"Multifocal papillary thyroid microcarcinomas: is the total tumor diameter associated with the tumor behavior? A retrospective cohort study.","authors":"Larissa Ariane de Nardi, Ana Flávia Aguiar Ribeiro Coutinho, Carlos Segundo Paiva Soares, Simone Antunes Terra, Cristiano Claudino de Oliveira, Katia Hiromoto Koga, Sonia Marta Moriguchi, José Vicente Tagliarini, Gláucia Maria Ferreira da Silva Mazeto","doi":"10.31744/einstein_journal/2025AO1724","DOIUrl":"10.31744/einstein_journal/2025AO1724","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate whether the total tumor diameter (sum of the largest diameters of all foci) predicts tumor aggressiveness at initial presentation and treatment response at 1-year follow-up in patients with multifocal papillary thyroid microcarcinoma.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 475 patients with differentiated thyroid carcinoma. Fifty-two patients with multifocal papillary thyroid microcarcinoma were included. The primary variable was total tumor diameter, and outcomes included initial tumor aggressiveness, evaluated according to the American Joint Committee on Cancer (AJCC; stages I or II), risk of recurrence according to the American Thyroid Association (low or not low), and response to therapy at 1 year (excellent or not).</p><p><strong>Results: </strong>AJCC stage II disease was significantly associated with age ≥55 years, lymph node dissection, angiolymphatic invasion, extrathyroidal extension, lymph node metastasis, number of metastatic lymph nodes, non-low risk of recurrence, first stimulated thyroglobulin, and response to therapy at 1-year. Non-low risk of recurrence were associated with Bethesda V/VI cytology, lymph node dissection, angiolymphatic and tumor capsule invasion, extrathyroidal extension, lymph node metastasis, number of metastatic lymph nodes, first stimulated thyroglobulin, and radioiodine dose. Non-excellent response at 1-year follow-up were associated with preoperative thyroid-stimulating hormone levels, lymph node metastasis, number of metastatic lymph nodes, and first stimulated thyroglobulin. Multivariate analysis revealed that only the number of metastatic lymph nodes independently predicted AJCC stage.</p><p><strong>Conclusion: </strong>Total tumor diameter was not associated with initial tumor aggressiveness or treatment response at 1-year follow-up in patients with multifocal papillary thyroid microcarcinoma.</p><p><strong>Background: </strong>■ In multifocal papillary thyroid microcarcinomas.</p><p><strong>Background: </strong>■ The total tumor diameter was not associated with aggressiveness or initial evolution.</p><p><strong>Background: </strong>■ Other factors are associated with disease outcomes.</p><p><strong>Background: </strong>■ The number of metastatic lymph nodes is an independent predictor of American Joint Committee on Cancer stage.</p><p><strong>Background: </strong>This study demonstrated that in multifocal papillary thyroid microcarcinomas, the sum of the largest diameters of all tumor foci was not associated with tumor aggressiveness or response to therapy at 1-year follow-up. Conversely, the total number of metastatic lymph nodes was an independent predictor of American Joint Committee on Cancer staging.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eAO1724"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis. 分子通路的相互关联研究:miR-137在脂质代谢和前列腺癌发生的交叉点上是一个中心元素。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025AO1601
Karina Serafim da Silva, Vanessa Ribeiro Guimarães, Feres Camargo Maluf, Gabriel Arantes Dos Santos, Juliana Alves de Camargo, Iran Amorim da Silva, Katia Ramos Moreira Leite, Sabrina Thalita Dos Reis, Nayara Izabel Viana, Miguel Srougi, Ruan Pimenta
<p><strong>Objective: </strong>To evaluate the roles of miR-137 and its target genes in lipid metabolism and prostate tumorigenesis.</p><p><strong>Methods: </strong>We used a series of bioinformatic approaches to establish the relationship between miR-137 and its target genes. We mapped the metabolic pathways of interest in the Reactome database and identified the central target genes of miR-137 in this pathway using four platforms: Reactome, miRDB, miRmap, and TargetScan. To assess the expression and association with clinical parameters, we obtained information from the UALCAN, OncoDB, and GEPIA2 databases using a dataset of patients with prostate cancer from The Cancer Genome Atlas. For functional enrichment analysis and construction of the protein-protein interaction network, we used the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and STRING.</p><p><strong>Results: </strong>Our in silico study of The Cancer Genome Atlas database revealed that miR-137 is underexpressed in tumor tissues, and its reduction is associated with poor prognosis. An intriguing set of eight genes within the PPARα pathway: PPARGC1A, PPARGC1B, NCOA1, NCOA2, NCOA3, MED1, MED27, and ESRRA displayed synergy, positive correlations, and synchronized expression patterns in adipose, hepatic, and prostatic tissues, all linked to the enigmatic processes of metabolic regulation. Among the highlighted genes, ESRRA was overexpressed in the malignant environment, whereas its counterparts remained underexpressed. The plot was thickened with associations between the expression of NCOA1, NCOA3, and MED27, lymph node involvement, and the overexpression of several genes linked to advanced prostate cancer stages. An intriguing pattern emerged, with patients exhibiting reduced disease-free survival overexpressing NCOA2, NCOA3, MED27, and ESRRA.</p><p><strong>Conclusion: </strong>This study elucidates the possibility that miR-137 subtly modulates metabolic genes in prostate cancer, suggesting its latent therapeutic potential as a biomarker for disease progression.</p><p><strong>Background: </strong>■ The reduction of miR-137 in tumor tissues is associated with a worse prognosis.</p><p><strong>Background: </strong>■ miR-137 has eight oncogenically relevant target genes acting in the PPARα lipid pathway.</p><p><strong>Background: </strong>■ NCOA1, NCOA3, MED27, and ESRRA are associated with advanced prostate cancer.</p><p><strong>Background: </strong>■ miR-137 exhibits significant clinical potential by repressing the activation of pathways that influence prostate tumorigenesis in hyperstimulated metabolic environments.</p><p><strong>Background: </strong>Prostate cancer progression is sustained by the simultaneous activation of pathways involving lipid uptake and de novo synthesis. In this context, miR-137 inhibits adipogenic differentiation and may reduce lipid uptake by tumor cells by modulating the PPAR/ p160/ESRRA axis, considerably attenuating metabolic effects and suppressing p
目的:探讨miR-137及其靶基因在脂质代谢和前列腺肿瘤发生中的作用。方法:采用一系列生物信息学方法建立miR-137与其靶基因之间的关系。我们在Reactome数据库中绘制了感兴趣的代谢途径,并使用四个平台(Reactome、miRDB、miRmap和TargetScan)确定了该途径中miR-137的中心靶基因。为了评估其表达及其与临床参数的关联,我们使用来自the cancer Genome Atlas的前列腺癌患者数据集,从UALCAN、OncoDB和GEPIA2数据库中获取信息。为了进行功能富集分析和蛋白质-蛋白质相互作用网络的构建,我们使用了京都基因和基因组百科全书、基因本体和STRING。结果:我们对The Cancer Genome Atlas数据库的计算机研究显示,miR-137在肿瘤组织中低表达,其降低与预后不良有关。在PPARα通路中,一组有趣的8个基因:PPARGC1A, PPARGC1B, NCOA1, NCOA2, NCOA3, MED1, MED27和ESRRA在脂肪,肝脏和前列腺组织中显示出协同作用,正相关和同步表达模式,所有这些都与代谢调节的神秘过程有关。在突出显示的基因中,ESRRA在恶性环境中过度表达,而其对应基因则保持低表达。随着NCOA1、NCOA3和MED27的表达、淋巴结受累以及与晚期前列腺癌相关的几个基因的过表达,该图变得更厚。一个有趣的模式出现了,患者表现出过表达NCOA2、NCOA3、MED27和ESRRA的无病生存率降低。结论:本研究阐明了miR-137微妙调节前列腺癌代谢基因的可能性,表明其作为疾病进展的生物标志物具有潜在的治疗潜力。背景:■肿瘤组织中miR-137的降低与较差的预后相关。背景:miR-137在PPARα脂质途径中具有8个与肿瘤相关的靶基因。背景:NCOA1、NCOA3、MED27和ESRRA与晚期前列腺癌相关。背景:在高刺激的代谢环境中,miR-137通过抑制影响前列腺肿瘤发生的通路的激活,显示出显著的临床潜力。背景:前列腺癌的进展是通过脂质摄取和新生合成途径的同时激活来维持的。在这种情况下,miR-137抑制脂肪生成分化,并可能通过调节PPAR/ p160/ESRRA轴减少肿瘤细胞的脂质摄取,显著减弱代谢作用并抑制前列腺肿瘤发生。
{"title":"Interconnected study of molecular pathways: miR-137 as a central element at the intersection of lipid metabolism and prostate carcinogenesis.","authors":"Karina Serafim da Silva, Vanessa Ribeiro Guimarães, Feres Camargo Maluf, Gabriel Arantes Dos Santos, Juliana Alves de Camargo, Iran Amorim da Silva, Katia Ramos Moreira Leite, Sabrina Thalita Dos Reis, Nayara Izabel Viana, Miguel Srougi, Ruan Pimenta","doi":"10.31744/einstein_journal/2025AO1601","DOIUrl":"10.31744/einstein_journal/2025AO1601","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the roles of miR-137 and its target genes in lipid metabolism and prostate tumorigenesis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We used a series of bioinformatic approaches to establish the relationship between miR-137 and its target genes. We mapped the metabolic pathways of interest in the Reactome database and identified the central target genes of miR-137 in this pathway using four platforms: Reactome, miRDB, miRmap, and TargetScan. To assess the expression and association with clinical parameters, we obtained information from the UALCAN, OncoDB, and GEPIA2 databases using a dataset of patients with prostate cancer from The Cancer Genome Atlas. For functional enrichment analysis and construction of the protein-protein interaction network, we used the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and STRING.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Our in silico study of The Cancer Genome Atlas database revealed that miR-137 is underexpressed in tumor tissues, and its reduction is associated with poor prognosis. An intriguing set of eight genes within the PPARα pathway: PPARGC1A, PPARGC1B, NCOA1, NCOA2, NCOA3, MED1, MED27, and ESRRA displayed synergy, positive correlations, and synchronized expression patterns in adipose, hepatic, and prostatic tissues, all linked to the enigmatic processes of metabolic regulation. Among the highlighted genes, ESRRA was overexpressed in the malignant environment, whereas its counterparts remained underexpressed. The plot was thickened with associations between the expression of NCOA1, NCOA3, and MED27, lymph node involvement, and the overexpression of several genes linked to advanced prostate cancer stages. An intriguing pattern emerged, with patients exhibiting reduced disease-free survival overexpressing NCOA2, NCOA3, MED27, and ESRRA.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This study elucidates the possibility that miR-137 subtly modulates metabolic genes in prostate cancer, suggesting its latent therapeutic potential as a biomarker for disease progression.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;■ The reduction of miR-137 in tumor tissues is associated with a worse prognosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;■ miR-137 has eight oncogenically relevant target genes acting in the PPARα lipid pathway.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;■ NCOA1, NCOA3, MED27, and ESRRA are associated with advanced prostate cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;■ miR-137 exhibits significant clinical potential by repressing the activation of pathways that influence prostate tumorigenesis in hyperstimulated metabolic environments.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Prostate cancer progression is sustained by the simultaneous activation of pathways involving lipid uptake and de novo synthesis. In this context, miR-137 inhibits adipogenic differentiation and may reduce lipid uptake by tumor cells by modulating the PPAR/ p160/ESRRA axis, considerably attenuating metabolic effects and suppressing p","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eAO1601"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144974005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atrophic hypothyroidism associated with thyrotropin receptor antibodies. 萎缩性甲状腺功能减退与促甲状腺素受体抗体相关。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025RC1400
Marcos Tadashi Kakitani Toyoshima, Camila Regina Pereira Batista de Macedo, Isabelle Pinheiro Amaro de Magalhaes, Janaina Almeida de Souza, Giulianno Dias da Rocha, Suemi Marui

Hypothyroidism is most frequently caused by Hashimoto's thyroiditis. While thyrotropin receptor antibodies are well-known in Graves' disease-induced hyperthyroidism, their role in hypothyroidism is emerging. We report the case of a 37-year-old woman with facial and periorbital edema, weight gain, and hoarseness suggestive of hypothyroidism. Elevated thyroid stimulating hormone (TSH; 131mIU/L) and decreased free thyroxine (0.2ng/dL, 2.6pmol/L) levels confirmed this diagnosis. Laboratory findings showed dyslipidemia, impaired renal function, elevated creatine phosphokinase levels, and anemia. Despite negative results for thyroid peroxidase (TPO-Ab) and thyroglobulin (TgAb) antibodies, positive thyrotropin receptor antibodies (11IU/L) suggested an autoimmune etiology. Thyroid ultrasound confirmed atrophic thyroiditis. Levothyroxine treatment improved the symptoms and laboratory values. Two months after diagnosis, the patient became pregnant. Anemia relapsed during pregnancy, thyrotropin receptor antibodies levels normalized, and postpartum follow-up revealed stable thyroid function without affecting the newborn thyroid function. This case underscores the diagnostic challenges of negative TPOAb and TgAb hypothyroidism, which is often misdiagnosed as Hashimoto's thyroiditis, and highlights the need for functional discrimination in thyrotropin receptor antibodies assays. Thyrotropin receptor antibodies measurements can help in the differential diagnosis of rapidly evolving hypothyroidism in women with negative TPO-Ab and thyrotropin receptor antibodies levels, especially in women of childbearing age. Further research is essential to understand thyrotropin-binding inhibitory immunoglobulin-mediated hypothyroidism and to develop targeted therapies.

甲状腺功能减退症最常由桥本甲状腺炎引起。虽然促甲状腺激素受体抗体在格雷夫斯病引起的甲状腺功能亢进中是众所周知的,但它们在甲状腺功能减退中的作用正在出现。我们报告的情况下,37岁的妇女面部和眶周水肿,体重增加,声音嘶哑提示甲状腺功能减退。促甲状腺激素(TSH; 131mIU/L)升高和游离甲状腺素(0.2ng/dL, 2.6pmol/L)水平降低证实了这一诊断。实验室结果显示血脂异常、肾功能受损、肌酸磷酸激酶水平升高和贫血。尽管甲状腺过氧化物酶(TPO-Ab)和甲状腺球蛋白(TgAb)抗体阴性,促甲状腺素受体抗体阳性(11IU/L)提示自身免疫性病因。甲状腺超声证实萎缩性甲状腺炎。左旋甲状腺素治疗改善了症状和实验室指标。确诊两个月后,患者怀孕了。妊娠期贫血复发,促甲状腺激素受体抗体水平恢复正常,产后随访甲状腺功能稳定,未影响新生儿甲状腺功能。该病例强调了TPOAb和TgAb阴性甲状腺功能减退症的诊断挑战,TPOAb和TgAb阴性甲状腺功能减退症经常被误诊为桥本甲状腺炎,并强调了在促甲状腺素受体抗体检测中进行功能区分的必要性。促甲状腺素受体抗体检测有助于TPO-Ab和促甲状腺素受体抗体水平阴性的妇女,特别是育龄妇女迅速发展的甲状腺功能减退症的鉴别诊断。进一步的研究对了解促甲状腺素结合抑制性免疫球蛋白介导的甲状腺功能减退和开发靶向治疗是必要的。
{"title":"Atrophic hypothyroidism associated with thyrotropin receptor antibodies.","authors":"Marcos Tadashi Kakitani Toyoshima, Camila Regina Pereira Batista de Macedo, Isabelle Pinheiro Amaro de Magalhaes, Janaina Almeida de Souza, Giulianno Dias da Rocha, Suemi Marui","doi":"10.31744/einstein_journal/2025RC1400","DOIUrl":"10.31744/einstein_journal/2025RC1400","url":null,"abstract":"<p><p>Hypothyroidism is most frequently caused by Hashimoto's thyroiditis. While thyrotropin receptor antibodies are well-known in Graves' disease-induced hyperthyroidism, their role in hypothyroidism is emerging. We report the case of a 37-year-old woman with facial and periorbital edema, weight gain, and hoarseness suggestive of hypothyroidism. Elevated thyroid stimulating hormone (TSH; 131mIU/L) and decreased free thyroxine (0.2ng/dL, 2.6pmol/L) levels confirmed this diagnosis. Laboratory findings showed dyslipidemia, impaired renal function, elevated creatine phosphokinase levels, and anemia. Despite negative results for thyroid peroxidase (TPO-Ab) and thyroglobulin (TgAb) antibodies, positive thyrotropin receptor antibodies (11IU/L) suggested an autoimmune etiology. Thyroid ultrasound confirmed atrophic thyroiditis. Levothyroxine treatment improved the symptoms and laboratory values. Two months after diagnosis, the patient became pregnant. Anemia relapsed during pregnancy, thyrotropin receptor antibodies levels normalized, and postpartum follow-up revealed stable thyroid function without affecting the newborn thyroid function. This case underscores the diagnostic challenges of negative TPOAb and TgAb hypothyroidism, which is often misdiagnosed as Hashimoto's thyroiditis, and highlights the need for functional discrimination in thyrotropin receptor antibodies assays. Thyrotropin receptor antibodies measurements can help in the differential diagnosis of rapidly evolving hypothyroidism in women with negative TPO-Ab and thyrotropin receptor antibodies levels, especially in women of childbearing age. Further research is essential to understand thyrotropin-binding inhibitory immunoglobulin-mediated hypothyroidism and to develop targeted therapies.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eRC1400"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539823/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144974027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A prospective and longitudinal cohort study assessing postacute sequelae of SARS-CoV-2 infection in patients with cancer. 一项评估癌症患者SARS-CoV-2感染急性后后遗症的前瞻性和纵向队列研究
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025AO1139
Victor Figueiredo Leite, Maria Teresa Duarte Pereira da Cruz Lourenço, Christina Haas Tarabay, Agnes Ayumi Sewo Mori, Giseli Maria Neto, Thais Manfrinato Miola, Luciana da Costa, Celena Freire Friedrich, Telma Ribeiro Rodrigues, Jordana Balbinot, Elisabete Carrara-Angelis

Objective: Post-COVID symptoms are frequent and can be debilitating, particularly in individuals with cancer. However, their impact on this population remains unclear. This study aimed to prospectively assess the symptoms and impairments following COVID-19 hospitalization in patients with cancer, focusing on fatigue, nutritional status, speech and swallowing, anxiety, depression, and posttraumatic stress disorder symptoms.

Methods: This prospective observational cohort study included cancer survivors hospitalized with COVID-19 between June and December 2020. We assessed symptoms and impairments related to fatigue, independence in activities of daily living, speech and swallowing, voice, nutritional risk, anxiety/depression, and posttraumatic stress disorder. The participants were assessed at discharge and after 1, 3, 6 and 12 months.

Results: A total of 51 participants were included in the study. At the time of discharge, 98% had at least one of the following impairments: fatigue (68.6%), anxiety/depressive symptoms (17.7%), voice and speech impairments (19.6%), dysphagia (21.6%), or nutritional risk (45.1%). By one year, impairments persisted in 66% of the sample: fatigue (34.2%), anxiety/depressive symptoms (19.5%), voice and speech impairments (12.2%), and dysphagia (17.1%), with no participants remaining at nutritional risk. The participants reported no significant limitations in their daily living activities.

Conclusion: Cancer survivors hospitalized for COVID-19 presented with high levels of fatigue, nutritional risk, anxiety/depression, and posttraumatic stress disorder symptoms at discharge, with improvements in fatigue and nutrition after one year.

Background: ■ High fatigue and nutritional risk at discharge improved over one year in cancer survivors.

Background: ■ Psychological symptoms, such as anxiety, depression, and posttraumatic stress disorder, remained prevalent for one year.

Background: ■ 66% of patients had lasting symptoms or impairments after 12 months of follow-up.

Background: ■ Nutritional risk was resolved in the following year. A prospective study of 51 cancer survivors hospitalized for COVID-19 revealed high initial levels of fatigue, nutritional risk, anxiety/depression, and posttraumatic stress disorder symptoms, with impairments persisting in 66% of patients after 1 year. Nutritional risk was resolved; however, psychological, and physical symptoms remained prevalent and required continuous care.

目的:新冠肺炎后的症状很常见,可能会使人虚弱,尤其是癌症患者。然而,它们对这一群体的影响尚不清楚。本研究旨在前瞻性评估癌症患者在COVID-19住院后的症状和损伤,重点关注疲劳、营养状况、语言和吞咽、焦虑、抑郁和创伤后应激障碍症状。方法:这项前瞻性观察队列研究纳入了2020年6月至12月期间因COVID-19住院的癌症幸存者。我们评估了与疲劳、日常生活活动的独立性、言语和吞咽、声音、营养风险、焦虑/抑郁和创伤后应激障碍相关的症状和损伤。参与者在出院时以及1、3、6和12个月后进行评估。结果:本研究共纳入51名受试者。出院时,98%的患者至少有以下一种障碍:疲劳(68.6%)、焦虑/抑郁症状(17.7%)、声音和语言障碍(19.6%)、吞咽困难(21.6%)或营养风险(45.1%)。一年后,66%的样本存在损伤:疲劳(34.2%)、焦虑/抑郁症状(19.5%)、声音和语言障碍(12.2%)和吞咽困难(17.1%),没有参与者存在营养风险。参与者报告他们的日常生活活动没有明显的限制。结论:因COVID-19住院的癌症幸存者在出院时表现出高度疲劳、营养风险、焦虑/抑郁和创伤后应激障碍症状,一年后疲劳和营养状况有所改善。背景:癌症幸存者出院时的高疲劳和营养风险在一年内得到改善。心理症状,如焦虑、抑郁和创伤后应激障碍,持续了一年。背景:66%的患者在12个月的随访后有持续的症状或损伤。背景:■营养风险在次年得到解决。一项针对51名因COVID-19住院的癌症幸存者的前瞻性研究显示,最初的疲劳、营养风险、焦虑/抑郁和创伤后应激障碍症状水平很高,66%的患者在1年后仍存在损伤。营养风险得到解决;然而,心理和身体症状仍然普遍存在,需要持续护理。
{"title":"A prospective and longitudinal cohort study assessing postacute sequelae of SARS-CoV-2 infection in patients with cancer.","authors":"Victor Figueiredo Leite, Maria Teresa Duarte Pereira da Cruz Lourenço, Christina Haas Tarabay, Agnes Ayumi Sewo Mori, Giseli Maria Neto, Thais Manfrinato Miola, Luciana da Costa, Celena Freire Friedrich, Telma Ribeiro Rodrigues, Jordana Balbinot, Elisabete Carrara-Angelis","doi":"10.31744/einstein_journal/2025AO1139","DOIUrl":"10.31744/einstein_journal/2025AO1139","url":null,"abstract":"<p><strong>Objective: </strong>Post-COVID symptoms are frequent and can be debilitating, particularly in individuals with cancer. However, their impact on this population remains unclear. This study aimed to prospectively assess the symptoms and impairments following COVID-19 hospitalization in patients with cancer, focusing on fatigue, nutritional status, speech and swallowing, anxiety, depression, and posttraumatic stress disorder symptoms.</p><p><strong>Methods: </strong>This prospective observational cohort study included cancer survivors hospitalized with COVID-19 between June and December 2020. We assessed symptoms and impairments related to fatigue, independence in activities of daily living, speech and swallowing, voice, nutritional risk, anxiety/depression, and posttraumatic stress disorder. The participants were assessed at discharge and after 1, 3, 6 and 12 months.</p><p><strong>Results: </strong>A total of 51 participants were included in the study. At the time of discharge, 98% had at least one of the following impairments: fatigue (68.6%), anxiety/depressive symptoms (17.7%), voice and speech impairments (19.6%), dysphagia (21.6%), or nutritional risk (45.1%). By one year, impairments persisted in 66% of the sample: fatigue (34.2%), anxiety/depressive symptoms (19.5%), voice and speech impairments (12.2%), and dysphagia (17.1%), with no participants remaining at nutritional risk. The participants reported no significant limitations in their daily living activities.</p><p><strong>Conclusion: </strong>Cancer survivors hospitalized for COVID-19 presented with high levels of fatigue, nutritional risk, anxiety/depression, and posttraumatic stress disorder symptoms at discharge, with improvements in fatigue and nutrition after one year.</p><p><strong>Background: </strong>■ High fatigue and nutritional risk at discharge improved over one year in cancer survivors.</p><p><strong>Background: </strong>■ Psychological symptoms, such as anxiety, depression, and posttraumatic stress disorder, remained prevalent for one year.</p><p><strong>Background: </strong>■ 66% of patients had lasting symptoms or impairments after 12 months of follow-up.</p><p><strong>Background: </strong>■ Nutritional risk was resolved in the following year. A prospective study of 51 cancer survivors hospitalized for COVID-19 revealed high initial levels of fatigue, nutritional risk, anxiety/depression, and posttraumatic stress disorder symptoms, with impairments persisting in 66% of patients after 1 year. Nutritional risk was resolved; however, psychological, and physical symptoms remained prevalent and required continuous care.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eAO1139"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539863/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144974033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of a serious immersive virtual reality game in managing pain during venous or catheter procedures in Pediatric Oncology. 一个严肃的沉浸式虚拟现实游戏在小儿肿瘤学静脉或导管治疗过程中的疼痛管理的影响。
IF 0.9 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-09-01 eCollection Date: 2025-01-01 DOI: 10.31744/einstein_journal/2025AO1327
Michelle Zampar Silva, Luzia Iara Pfeifer, Barbara Jacomin, Juliana da Costa Feitosa, Raphael de Aro Sousa, José Remo Ferreira Brega, Davi Casale Aragon, Luiz Gonzaga Tone, Carlos Alberto Scrideli, Elvis Terci Valera

Objective: To analyze the impact of a serious immersive virtual reality game on the physiological and behavioral aspects of pain during peripheral venous access or central catheter puncture in children and adolescents with cancer.

Methods: This was a longitudinal intervention study that included 50 children and adolescents undergoing cancer therapy and peripheral venipuncture or venous catheter puncture (totally implanted or central venous catheter) at two independent time points (control and experimental intervention). The intervention consisted of playing a serious immersive virtual reality game with three-dimensional goggles and a Bluetooth controller. The patients were monitored for alterations in physiological (heart rate and oxygen saturation) and behavioral (agitation, crying, and pain assessed using the Faces Pain Scale-Revised and Visual Analogue Scale) parameters. An agreement analysis was conducted by calculating the weighted kappa coefficient; p was obtained using Bowker's symmetry test.

Results: Use of immersive virtual reality significantly reduced heart rate, improved pain control as assessed by the Faces Pain Scale-Revised, and decreased agitation and crying.

Conclusion: Serious immersive virtual reality games reduce pain and distress during repetitive and uncomfortable procedures such as venipuncture and venous catheter puncture in children and adolescents with cancer. This strategy is simple to implement, cost-effective, and should be considered by health care services assisting pediatric patients with cancer.

Background: ■ Immersive virtual reality reduced heart rate, pain, agitation, and crying during pediatric venipuncture.

Background: ■ This technology effectively reduced pain during repeated invasive procedures, including catheter punctures.

Background: ■ The serious game strategy is low-cost, easy to implement, and well-suited for pediatric oncology care.

Background: Various pain management strategies are employed for children undergoing cancer treatment. Silva et al. prospectively evaluated an innovative approach using an immersive serious game for pain control. The intervention significantly reduced pain perception during venipuncture. Herein, we evaluate immersive virtual reality for pain management in pediatric oncology care.

目的:分析一个严肃的沉浸式虚拟现实游戏对儿童和青少年癌症患者外周静脉通路或中心导管穿刺时疼痛的生理和行为方面的影响。方法:这是一项纵向干预研究,包括50名接受癌症治疗和外周静脉穿刺或静脉导管穿刺(完全植入或中心静脉导管)的儿童和青少年,在两个独立的时间点(对照组和实验干预)。干预包括用三维护目镜和蓝牙控制器玩一个严肃的沉浸式虚拟现实游戏。监测患者的生理(心率和血氧饱和度)和行为(激动、哭泣和疼痛,使用面部疼痛量表和视觉模拟量表进行评估)参数的改变。通过计算加权kappa系数进行一致性分析;p由Bowker对称检验得到。结果:沉浸式虚拟现实的使用显著降低了心率,改善了面部疼痛量表-修订版评估的疼痛控制,减少了躁动和哭泣。结论:严肃的沉浸式虚拟现实游戏可以减轻患有癌症的儿童和青少年在进行静脉穿刺和静脉导管穿刺等重复性和不舒服的手术时的疼痛和困扰。这一策略易于实施,具有成本效益,应被帮助患有癌症的儿科患者的卫生保健服务机构考虑。背景:■沉浸式虚拟现实可以降低儿童静脉穿刺时的心率、疼痛、躁动和哭泣。背景:■该技术有效地减少了包括导管穿刺在内的多次侵入性手术的疼痛。背景:■严肃游戏策略成本低,易于实施,非常适合儿科肿瘤护理。背景:各种疼痛管理策略被用于接受癌症治疗的儿童。Silva等人前瞻性地评估了一种使用沉浸式严肃游戏来控制疼痛的创新方法。干预显著降低了静脉穿刺时的痛觉。在此,我们评估沉浸式虚拟现实的疼痛管理在儿科肿瘤护理。
{"title":"Impact of a serious immersive virtual reality game in managing pain during venous or catheter procedures in Pediatric Oncology.","authors":"Michelle Zampar Silva, Luzia Iara Pfeifer, Barbara Jacomin, Juliana da Costa Feitosa, Raphael de Aro Sousa, José Remo Ferreira Brega, Davi Casale Aragon, Luiz Gonzaga Tone, Carlos Alberto Scrideli, Elvis Terci Valera","doi":"10.31744/einstein_journal/2025AO1327","DOIUrl":"10.31744/einstein_journal/2025AO1327","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the impact of a serious immersive virtual reality game on the physiological and behavioral aspects of pain during peripheral venous access or central catheter puncture in children and adolescents with cancer.</p><p><strong>Methods: </strong>This was a longitudinal intervention study that included 50 children and adolescents undergoing cancer therapy and peripheral venipuncture or venous catheter puncture (totally implanted or central venous catheter) at two independent time points (control and experimental intervention). The intervention consisted of playing a serious immersive virtual reality game with three-dimensional goggles and a Bluetooth controller. The patients were monitored for alterations in physiological (heart rate and oxygen saturation) and behavioral (agitation, crying, and pain assessed using the Faces Pain Scale-Revised and Visual Analogue Scale) parameters. An agreement analysis was conducted by calculating the weighted kappa coefficient; p was obtained using Bowker's symmetry test.</p><p><strong>Results: </strong>Use of immersive virtual reality significantly reduced heart rate, improved pain control as assessed by the Faces Pain Scale-Revised, and decreased agitation and crying.</p><p><strong>Conclusion: </strong>Serious immersive virtual reality games reduce pain and distress during repetitive and uncomfortable procedures such as venipuncture and venous catheter puncture in children and adolescents with cancer. This strategy is simple to implement, cost-effective, and should be considered by health care services assisting pediatric patients with cancer.</p><p><strong>Background: </strong>■ Immersive virtual reality reduced heart rate, pain, agitation, and crying during pediatric venipuncture.</p><p><strong>Background: </strong>■ This technology effectively reduced pain during repeated invasive procedures, including catheter punctures.</p><p><strong>Background: </strong>■ The serious game strategy is low-cost, easy to implement, and well-suited for pediatric oncology care.</p><p><strong>Background: </strong>Various pain management strategies are employed for children undergoing cancer treatment. Silva et al. prospectively evaluated an innovative approach using an immersive serious game for pain control. The intervention significantly reduced pain perception during venipuncture. Herein, we evaluate immersive virtual reality for pain management in pediatric oncology care.</p>","PeriodicalId":47359,"journal":{"name":"Einstein-Sao Paulo","volume":"23 ","pages":"eAO1327"},"PeriodicalIF":0.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12539856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144974016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Einstein-Sao Paulo
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1